title: IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion.
abstract: Our previous studies have shown that insulin-like growth factor binding protein 2 (IGFBP-2) is frequently overexpressed in the highly invasive glioblastoma multiforme (GBM). By using a yeast two-hybrid system, we identified a gene, invasion inhibitory protein 45 (IIp45), whose protein product bound to IGFBP-2 through the thyroglobulin-RGD region of the C terminus of IGFBP-2. The IIp45 gene is located on chromosome 1p36 and has nine exons. The IIp45 protein has three SEG (segment of low compositional complexity) domains and an integrin-binding RGD motif. The IIp45 protein was not expressed in some GBMs. Functional studies showed that IIp45 inhibited GBM cell invasion both in vitro and in xenograft model. Gene expression profiling studies showed that IIp45 consistently inhibited the expression of cell invasion-associated genes, such as the transcriptional NFkappaB, and its downstream target gene, intercellular adhesion molecule 1. Thus, we report here the isolation and characterization of a gene, IIp45, whose protein product binds to IGFBP-2 and inhibits glioma cell invasion.
authors: Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
authors: Sonya W
authors: SW
authors: Song
authors: Gregory N
authors: GN
authors: Fuller
authors: Asadullah
authors: A
authors: Khan
authors: Shouming
authors: S
authors: Kong
authors: Weiping
authors: W
authors: Shen
authors: Ellen
authors: E
authors: Taylor
authors: Latha
authors: L
authors: Ramdas
authors: Frederick F
authors: FF
authors: Lang
authors: Wei
authors: W
authors: Zhang
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D000818:Animals; D001921:Brain / Q000378:metabolism; D001932:Brain Neoplasms / Q000378:metabolism / Q000473:pathology; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D002460:Cell Line; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D015536:Down-Regulation / Q000187:drug effects; D005910:Glioma / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology*; D006801:Humans; D066298:In Vitro Techniques; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics; D047908:Intracellular Signaling Peptides and Proteins; D051379:Mice; D008819:Mice, Nude; D008969:Molecular Sequence Data; D016328:NF-kappa B / Q000235:genetics; D009361:Neoplasm Invasiveness; D020798:Two-Hybrid System Techniques
chemical_list: D002352:Carrier Proteins; D018971:Insulin-Like Growth Factor Binding Protein 2; D047908:Intracellular Signaling Peptides and Proteins; C480900:MIIP protein, human; D016328:NF-kappa B; D018799:Intercellular Adhesion Molecule-1